Inogla-M 500 Tablet ER
Inogla-M 500 Tablet ER
Metformin (500mg) + Teneligliptin (20mg)
Ecoglip-TM Tablet PR
Ozone Pharmaceuticals Ltd
Metformin 500mg
Pack Size
1 units
Price
Save ₹105
that's 74% off!
About This Medicine
Product description & overview
Inogla-M 500 Tablet ER: A Dual-Action Approach to Blood Sugar Management
Inogla-M 500 Tablet ER is a once-daily, extended-release combination medication used for the treatment of type 2 diabetes. This unique formulation contains metformin (500mg) and teneligliptin (20mg), two powerful ingredients working together to achieve optimal blood sugar control.
Metformin, a first-line therapy for diabetes, helps improve insulin sensitivity in the body's cells, leading to better glucose uptake. This contributes to lower overall blood sugar levels.
Teneligliptin, on the other hand, specifically targets dipeptidyl peptidase-4 (DPP-4) enzymes, which regulate the release of incretin hormones from within the body. By inhibiting these enzymes, teneligliptin increases incretins’ activity, further enhancing glucose uptake and reducing blood sugar levels.
This combination therapy provides a well-rounded approach to managing type 2 diabetes by tackling blood sugar at multiple levels.
Active composition
Teneligliptin 20 mg
+1 more active ingredient
About Teneligliptin
Teneligliptin is an anti-diabetic medication used to manage type 2 diabetes. It enhances insulin secretion and regulates blood sugar levels. Its clinical relevance lies in effectively controlling diabetes. In summary, Teneligliptin is vital for diabetes management.
How It Works
Teneligliptin inhibits DPP-4, increasing incretin levels and enhancing insulin secretion.
All Active Ingredients
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Pregnancy
Inogla-M 500 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Inogla-M 500 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Inogla-M 500 Tablet ER may be needed. Please consult your doctor. Use of Inogla-M 500 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Breastfeeding
It is not known whether Inogla-M 500 Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Kidney
Inogla-M 500 Tablet ER is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Inogla-M 500 Tablet ER